Galnon
Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue propertiesGalnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury[1]. Galnon, a GAL receptor agonist, may enhance osteoclastic bone resorption in OVX rats. Although galnon reduced bone volume, biomechanical testing revealed that bone of galnon-treated animals was mechanically superior per unit area. Taken together, galnon simultaneously improves the intrinsic quality of cortical bone whilst stimulating osteoclastic activity in the OVX rat model.
Product Specifications
CAS Number
475115-35-6
Purity
>98% (HPLC)
Smiles
Cc1cc (=O) oc2cc (NC (=O) [C@H] (CCCCN) NC (=O) [C@H] (CC3CCCCC3) NC (=O) OCC3c4ccccc4-c4ccccc34) ccc12
Molecular Formula
C40H46N4O6
Molecular Weight
678.83
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
LMTK2, NT (Lemur Tyrosine Kinase 2, LMR2, Apoptosis-associated Tyrosine Kinase 2, AATYK2, Brain-enriched Kinase, BREK, hBREK, CDK5/p35-regulated Kinase, CPRK, FLJ46659, KIAA1079, Kinase/phosphatase/inhibitor 2, KPI2, KPI-2, Serine/threonine-protein Kinase